Alimera Sciences Inc (ALIM)
3.71
+0.04
(+1.09%)
USD |
NASDAQ |
Apr 30, 16:00
Alimera Sciences Cash from Financing (Quarterly): -0.078M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.078M |
| September 30, 2023 | -0.546M |
| June 30, 2023 | 87.12M |
| March 31, 2023 | 9.998M |
| December 31, 2022 | -0.193M |
| September 30, 2022 | 0.055M |
| June 30, 2022 | -0.102M |
| March 31, 2022 | -0.062M |
| December 31, 2021 | -0.019M |
| September 30, 2021 | -0.049M |
| June 30, 2021 | 9.948M |
| March 31, 2021 | -0.057M |
| December 31, 2020 | -0.046M |
| September 30, 2020 | -0.11M |
| June 30, 2020 | 1.623M |
| March 31, 2020 | 2.415M |
| December 31, 2019 | 1.069M |
| September 30, 2019 | -0.058M |
| June 30, 2019 | -0.032M |
| March 31, 2019 | -0.11M |
| December 31, 2018 | -0.025M |
| September 30, 2018 | -0.203M |
| June 30, 2018 | -0.055M |
| March 31, 2018 | 1.233M |
| December 31, 2017 | -0.03M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.889M |
| June 30, 2017 | 2.899M |
| March 31, 2017 | -0.038M |
| December 31, 2016 | -0.16M |
| September 30, 2016 | 25.74M |
| June 30, 2016 | 0.308M |
| March 31, 2016 | -0.466M |
| December 31, 2015 | 0.839M |
| September 30, 2015 | 0.083M |
| June 30, 2015 | -0.092M |
| March 31, 2015 | -0.205M |
| December 31, 2014 | 50.01M |
| September 30, 2014 | 25.00M |
| June 30, 2014 | 4.752M |
| March 31, 2014 | 34.98M |
| December 31, 2013 | -0.107M |
| September 30, 2013 | -0.034M |
| June 30, 2013 | 2.257M |
| March 31, 2013 | -0.462M |
| December 31, 2012 | 38.90M |
| September 30, 2012 | -0.499M |
| June 30, 2012 | -0.672M |
| March 31, 2012 | -0.571M |
| December 31, 2011 | -0.427M |
| September 30, 2011 | -0.229M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.546M
Minimum
Sep 2023
87.12M
Maximum
Jun 2023
5.836M
Average
-0.046M
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| Eli Lilly and Co | 3.545B |
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | -1.457M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.77M |
| Cash from Investing (Quarterly) | -0.085M |
| Free Cash Flow | -89.79M |
| Free Cash Flow Per Share (Quarterly) | 0.0704 |
| Free Cash Flow to Equity (Quarterly) | 3.418M |
| Free Cash Flow to Firm (Quarterly) | 8.448M |
| Free Cash Flow Yield | -97.21% |